Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Dec 2025 for Spruce Biosciences, INC..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Samir M. Gharib: trading record in brief
Samir M. Gharib (finance chief) discloses dealings in Spruce Biosciences, Inc. to SEC (Form 4). We count 32 filings; the first trade dates from 30 June 2021 and the latest from 15 December 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 17 December 2025 came the latest disclosure, an option exercise in Spruce Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Samir M. Gharib
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
496 shares0Common StockSEC:0001533302-25-000011:0
514 shares0Common StockSEC:0001533302-25-000007:0
2,053 shares0Common StockSEC:0001533302-25-000004:0
154,000 shares0Common StockSEC:0001415889-24-030000:0
11,255 shares@ US$0.977517.5% of flowCommon StockSEC:0001209191-24-000336:0
75,000 shares0Common StockSEC:0001209191-23-059054:0
10,484 shares@ US$0.977516.6% of flowCommon StockSEC:0001209191-23-041250:0
1 shares@ US$0.93280.0% of flowCommon StockSEC:0001209191-23-002150:0
37,500 sharesCommon StockSEC:0001209191-22-040557:0
2,220 shares@ US$3.79119.5% of flowCommon StockSEC:0001209191-22-001621:0
1,412 shares@ US$9.528529.7% of flowCommon StockSEC:0001209191-21-045416:0
11 of 11 declarations
